{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:01:20Z","timestamp":1788940880591,"version":"build-2803163510"},"reference-count":22,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.2967\/jnumed.112.102897","type":"journal-article","created":{"date-parts":[[2012,6,24]],"date-time":"2012-06-24T00:17:26Z","timestamp":1340497046000},"page":"1200-1206","source":"Crossref","is-referenced-by-count":56,"title":["The Added Value of <sup>18<\/sup>F-FDG PET\/CT for Evaluation of Patients with Esthesioneuroblastoma"],"prefix":"10.2967","volume":"53","author":[{"given":"Stephen M.","family":"Broski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratham M.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Peller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"key":"2021051712034393000_53.8.1200.1","first-page":"2683","article-title":"Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924","volume":"17","author":"Broich","year":"1997","journal-title":"Anticancer Res."},{"key":"2021051712034393000_53.8.1200.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(01)00558-7"},{"key":"2021051712034393000_53.8.1200.3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L"},{"key":"2021051712034393000_53.8.1200.4","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.133.3.276"},{"key":"2021051712034393000_53.8.1200.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1360-6"},{"key":"2021051712034393000_53.8.1200.6","doi-asserted-by":"crossref","unstructured":"Morita A Ebersold MJ Olsen KD Foote RL Lewis JE Quast LM . Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32:706\u2013714.","DOI":"10.1097\/00006123-199305000-00002"},{"key":"2021051712034393000_53.8.1200.7","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.129.11.1186"},{"key":"2021051712034393000_53.8.1200.8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2401"},{"key":"2021051712034393000_53.8.1200.9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1259\/bjr.72.863.10700820","article-title":"Imaging of recurrent esthesioneuroblastoma","volume":"72","author":"Pickuth","year":"1999","journal-title":"Br J Radiol."},{"key":"2021051712034393000_53.8.1200.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-009-0581-0"},{"key":"2021051712034393000_53.8.1200.11","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1114"},{"key":"2021051712034393000_53.8.1200.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.rlu.0000200735.55296.73"},{"key":"2021051712034393000_53.8.1200.13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2214\/ajr.174.3.1740837","article-title":"Imaging-based nodal classification for evaluation of neck metastatic adenopathy","volume":"174","author":"Som","year":"2000","journal-title":"AJR."},{"key":"2021051712034393000_53.8.1200.14","doi-asserted-by":"publisher","DOI":"10.1097\/00020840-200304000-00009"},{"key":"2021051712034393000_53.8.1200.15","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.2.134"},{"key":"2021051712034393000_53.8.1200.16","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2009.143"},{"key":"2021051712034393000_53.8.1200.17","first-page":"763","article-title":"Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas","volume":"46","author":"Henze","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712034393000_53.8.1200.18","first-page":"1053","article-title":"PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas","volume":"42","author":"Henze","year":"2001","journal-title":"J Nucl Med."},{"key":"2021051712034393000_53.8.1200.19","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20356"},{"key":"2021051712034393000_53.8.1200.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0874-2"},{"key":"2021051712034393000_53.8.1200.21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3413\/nukmed-282","volume":"46","author":"Krause","year":"2007","journal-title":"Nuklearmedizin."},{"key":"2021051712034393000_53.8.1200.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.047787"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.112.102897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:40:48Z","timestamp":1621280448000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.112.102897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2012,8,1]]},"published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.2967\/jnumed.112.102897"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.112.102897","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,22]]}}}